The effect of DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors on cardiorenal outcomes: a network meta-analysis of 23 CVOTs

Overview of attention for article published in Cardiovascular Diabetology, March 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

So far, Altmetric has seen 31 tweets from 30 users, with an upper bound of 134,205 followers.

RT @CristobMorales: https://t.co/fDqECfvCVZ The effect of DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors on cardiorenal ou…

RT @CristobMorales: https://t.co/fDqECfvCVZ The effect of DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors on cardiorenal ou…

RT @CristobMorales: https://t.co/fDqECfvCVZ The effect of DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors on cardiorenal ou…

This page shows the most recent tweets that mention this research output.

Click here to find out how to access more activity, including 27 additional tweets.